July 26, 2024
Department of JusticeOffice of Public Affairs FOR IMMEDIATE RELEASEThursday, July 25, 2024 A federal grand jury in Houston returned an indictment today charging an Indian national […]
July 26, 2024
Department of JusticeU.S. Attorney’s OfficeDistrict of South Carolina FOR IMMEDIATE RELEASEFriday, July 25, 2024 GREENVILLE, S.C. — Richard A. Sheriff, 73, of Easley, has pleaded guilty to […]
July 26, 2024
The incidence of tick-borne illnesses in Canada is on the rise. Diseases that were once limited to the United States have spread north, and rare infections […]
July 26, 2024
The European Medicines Agency (EMA) has recommended strengthening existing advice to minimize the risks from interactions between Mysimba (naltrexone/bupropion; Orexigen Therapeutics Ireland Limited) and opioid-containing medicines. […]
July 26, 2024
Delivery Method: Via Email [email protected] Product: Drugs Recipient: Recipient Name James P. Morrissette Recipient Title CEO Premier Manufacturing Products, LLC 912 46th Lane Unit 204Cape Coral, […]
July 26, 2024
A drug to treat severe itching in patients with Alagille syndrome should be granted a marketing authorization in the European Union under what the European Medicines […]
July 26, 2024
Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of marketing authorization for Anzupgo (delgocitinib; LEO Pharma) to treat moderate to severe chronic […]
July 26, 2024
The US Food and Drug Administration (FDA) has approved the oral Janus kinase (JAK) inhibitor deuruxolitinib for the treatment of adults with severe alopecia areata. The […]
July 26, 2024
In its July 2024 meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended not granting marketing authorization for […]